Inventory increased 65.6%
Inventory changed +65.6% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Inventory changed +65.6% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Operating income changed -43.5% from the comparable as-filed period.
Gross margin changed +13982 basis points from the comparable as-filed period.
Operating margin changed -17779 basis points from the comparable as-filed period.
Current ratio changed -35.7% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Working capital / assets changed +13734 basis points from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Current liabilities changed +67.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Research & development changed -46.1% from the comparable as-filed period.
Total assets changed +202.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Working capital changed -74.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Revenue changed -22.8% from the comparable as-filed period.
Selling, general & administrative changed +40.9% from the comparable as-filed period.
Inventory / revenue changed +2913 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.